A resolution recognizing the 25th anniversary of the Foundation for the National Institutes of Health and its critical role in America's biomedical research strategy by advancing biomedical research and the mission of the National Institutes of Health, the world's premier biomedical research agency.

III 117TH CONGRESS 1ST SESSION S. RES. 281 Recognizing the 25th anniversary of the Foundation for the National Insti- tutes of Health and its critical role in America’s biomedical research strategy by advancing biomedical research and the mission of the Na- tional Institutes of Health, the world’s premier biomedical research agen- cy. IN THE SENATE OF THE UNITED STATES JUNE 22, 2021 Mrs. MURRAY (for herself and Mr. BURR) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions RESOLUTION Recognizing the 25th anniversary of the Foundation for the National Institutes of Health and its critical role in America’s biomedical research strategy by advancing bio- medical research and the mission of the National Insti- tutes of Health, the world’s premier biomedical research agency. Whereas Congress chartered the Foundation for the National Institutes of Health (referred to in this preamble as the ‘‘FNIH’’) to support the mission of the National Insti- tutes of Health (referred to in this preamble as the ‘‘NIH’’), which is to advance research in pursuit of fun- damental knowledge that will lead to better health out- comes for all; VerDate Sep 11 2014 20:41 Jun 24, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\SR281.IS SR281 pamtmann on DSKBC07HB2PROD with BILLS 2 •SRES 281 IS Whereas June 26, 2021, marks 25 years since FNIH com- menced its work to improve health outcomes for the peo- ple of the United States by facilitating groundbreaking research and catalyzing innovation and discovery to an- swer the toughest scientific questions; Whereas FNIH is recognized by Congress, NIH, and the bio- medical community as a model for aligning public and private partners around a common cause that advances breakthrough biomedical discoveries and improves the quality of people’s lives; Whereas, among the hundreds of programs FNIH has facili- tated, the Grand Challenges in Global Health partner- ship, founded in collaboration with the Bill & Melinda Gates Foundation, achieved scientific breakthroughs against deadly diseases in the world’s poorest countries and elevated the role of FNIH as a leader in building al- liances for biomedical research; Whereas FNIH, NIH, and the Food and Drug Administra- tion of the Department of Health and Human Services launched the Accelerating Medicines Partnership as a public-private collaboration to pursue new methods to de- velop diagnostics and treatments for Alzheimer’s disease, type 2 diabetes, autoimmune disorders, Parkinson’s dis- ease, and schizophrenia; Whereas the FNIH created a new model for clinical trials through initiatives to fight breast cancer and lung cancer, continues to bring together partners to identify, develop, and qualify biomarkers to improve drug discovery and regulatory decision making, and recognizes and supports trailblazing researchers, some of whom have won other prestigious scientific prizes, including the Nobel Prize; VerDate Sep 11 2014 20:41 Jun 24, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\SR281.IS SR281 pamtmann on DSKBC07HB2PROD with BILLS 3 •SRES 281 IS Whereas FNIH supports caregivers of NIH Clinical Center patients through the Edmond J. Safra Family Lodge, a temporary residence for caregivers whose close presence helps to sustain patients who volunteer for NIH research that was constructed and is maintained by the FNIH on the NIH campus; Whereas FNIH answered NIH’s call to action to address the largest pandemic in a century by launching and coordi- nating the Accelerating COVID–19 Therapeutic Interven- tions and Vaccines (‘‘ACTIV’’) initiative in partnership with numerous government agencies, not-for-profit orga- nizations, and biopharmaceutical companies to accelerate the most promising COVID–19 vaccines and treatments; and Whereas FNIH remains an indispensable institution to the biomedical research mission of the NIH and the people of the United States: Now, therefore, be it Resolved, That the Senate— 1 (1) celebrates the 25th anniversary of the 2 Foundation for the National Institutes of Health 3 and its critical role in advancing biomedical research 4 and the mission of the National Institutes of Health, 5 the world’s premier biomedical research agency; 6 (2) applauds the Foundation for the National 7 Institutes of Health for its leadership and ongoing 8 efforts to advance human health outcomes through 9 innovative public-private partnerships that achieve 10 groundbreaking biomedical research results; 11 VerDate Sep 11 2014 20:41 Jun 24, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\SR281.IS SR281 pamtmann on DSKBC07HB2PROD with BILLS 4 •SRES 281 IS (3) commends the Foundation for the National 1 Institutes of Health for its efforts to address the 2 COVID–19 pandemic through the Accelerating 3 COVID–19 Therapeutic Interventions and Vaccines 4 initiative and accelerate the development of the most 5 promising treatments and vaccines for COVID–19; 6 and 7 (4) reiterates that the Foundation for the Na- 8 tional Institutes of Health, in partnership with the 9 National Institutes of Health, is a vital and essential 10 component of biomedical research strategy of the 11 United States. 12 Æ VerDate Sep 11 2014 20:41 Jun 24, 2021 Jkt 019200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6301 E:\BILLS\SR281.IS SR281 pamtmann on DSKBC07HB2PROD with BILLS